Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Venkatesh, Goutham Hassan ^a   Manjunath, Vadhiraja Bejadi ^b   Mumbrekar, Kamalesh Dattaram ^a   Negi, Hitendra ^a   Fernandes, Donald Jerard ^d   Sharan, Krishna ^d   Banerjee, Sourjya ^c   Sadashiva, Satish Rao Bola ^a  

^a MANIPAL SCHOOL OF LIFE SCIENCES   (India)

^b MANIPAL HOSPITAL   (India)

^c KASTURBA MEDICAL COLLEGE   (India)

^d KASTURBA HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; DNA;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; ERYTHEMA; FEMALE; GENE DELETION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HEAD AND NECK CANCER; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL MUCOSITIS; RADIATION RESPONSE; RADIOSENSITIVITY; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; ALLELE; CHEMORADIOTHERAPY; DEMOGRAPHY; EPIDEMIOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIATION DOSE; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHEMORADIOTHERAPY; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEMOGRAPHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION TOLERANCE; RISK FACTORS;

EID: 84897037927     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089079     Document Type: Article

References (31)

1. Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47:1-12.
2. Safwat A, Bentzen SM, Turesson I, Hendry JH (2002) Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys 52:198-204. (Pubitemid 34041572)
3. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, et al. (2009) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9:134-142.
4. Ishikawa A, Suga T, Shoji Y, Kato S, Ohno T, et al. (2011) Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy. Int J Radiat Oncol Biol Phys 81:1144-52.
5. Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I, et al. (2007) The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 96:1001-1007. (Pubitemid 46452279)
6. Goutham HV, Mumbrekar KD, Vadhiraja BM, Fernandes DJ, Sharan K, et al. (2012) DNA Double-strand break analysis by c-H2AX Foci: a useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 84:e607-12.
7. Andreassen CA, Dikomey E, Parliament M, West CML (2012) Will SNPs be useful predictors of normal tissue radiosensitivity in the future? Radiother Oncol 105:283-288
8. Popanda O, Marquardt JU, Chang-Claude J, Schmezer P (2009) Genetic variation in normal tissue toxicity induced by ionizing radiation. Mut Res 667:58-69.
9. Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, et al. (2012) Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol 13: 65-77.
10. Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E (2003) A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 42:443-61. (Pubitemid 37193837)
11. Parliament MB, Murray D (2010) Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse. Semin Radiat Oncol 20:232-40.
12. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346.
13. Li Z, Zhang Z, He Z, Tang W, Li T, et al. (2009) A partition-ligation combinationsubdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Available: http://analysis.bio-x.cn. Cell Res 19:519-23.
14. Guerra JL, Gomez D, Wei Q, Liu Z, Wang LE, et al. (2012) Association between single nucleotide polymorphisms of the transforming growth factor b1 gene and the risk of severe radiation esophagitis in patients with lung cancer. Radiother Oncol 105:299-304.
15. Bentzen SM (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6:702-13.
16. West CM, Barnett GC (2012) Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med 3:e52.
17. Silva J, Teixeira AL, Lobo F, Maurício J, Medeiros R (2012) DNA repair system and prostate cancer progression: the role of NBS1 polymorphism (rs1805794). DNA Cell Biol 3: 1182-6.
18. Popanda O, Tan XL, Ambrosone CB, Kropp S, Helmbold I, et al. (2006) Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 15: 1048-50. (Pubitemid 43823540)
19. Millikan RC, Player JS, Decotret AR, Tse CK, Keku T (2012) Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2326-34.
20. Damaraju S, Murray D, Dufour J, Carandang D, Myrehaug S et al. (2006) Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 12: 2545-54.
21. Chang-Claude J, Ambrosone CB, Lilla C, Kropp S, Helmbold I, et al. (2009) Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer 100: 1680-6.
22. Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, et al. (2009) Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 73:1187-1195.
23. Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, et al. (2011) Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol 99:356-361.
24. Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, et al. (2006) Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Can Res 8:R40.
25. Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y, et al. (2008) IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res 14:6683-9.
26. Voets AM, Oberije C, Struijk RB, Reymen B, De Ruyck K, et al. (2012) No association between TGFb1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients. Radiother Oncol 105:296-8.
27. Reuther S, Metzke E, Bonin M, Petersen C, Dikomey E, et al. (2013) No effect of the transforming growth factor b1 promoter polymorphism c-509t on TGFb1 gene expression, protein secretion, or cellular radiosensitivity. Int J Radiat Oncol Biol Phys 85: 460-65.
28. Zschenker O, Raabe A, Boeckelmann IK, Borstelmann S, Szymczak S, et al. (2010) Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFb1, XPD and XRCC1 with clinical and cellular radiosensitivity, Radiother Oncol 97:26-32.
29. Suga T, Ishikawa A, Kohda M, Otsuka Y, Yamada S, et al. (2007) Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 69:685-93. (Pubitemid 47418413)
30. Schirmer MA, Brockmöller J, Rave-Fränk M, Virsik P, Wilken B, et al. (2011) A putatively functional haplotype in the gene encoding transforming growth factor beta- 1 as a potential biomarker for radiosensitivity. Int J Radiat Oncol Biol Phys 79:866-74.
31. Andreassen CN, Alsner J (2009) Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol 92:299-309.